Solutions To a Pressing Clinical Need.


High infection rates and a better understanding of underlying health impact increase the demand for screening for STI organisms including Chlamydia trachomatis (CT), Neisseria gonorrhoeae (GC), Herpes Simplex Virus 1 & 2 (HSV1 & HSV2)*, and Human Papillomavirus (HPV)* in targeted populations around the world.

This demand comes at a time when laboratories are challenged by the pressure to contain healthcare costs, a shortage of trained personnel and expectations to deliver more, and higher quality results.

BD has developed solutions that fulfill your screening and diagnostic needs with :

  • A clinically relevant menu
  • A range of molecular systems
  • Superior laboratory productivity and efficiency with Lean & "Six sigma" methodologies


Learn more about...


 
STI Archive»

Products & Services


1 - BD ProbeTec™ ET System »

2 - BD ProbeTec™ ET Reagents »

3- BD Affirm™ VP III Microbial Identification System »






Unless otherwise noted, BD, BD Logo and all other trademarks are property of Becton, Dickinson and Company. © 2014 BD